reported that during programmed cell death protein 1 (PD-1) antibody treatment, the secretion of IFN-γ by CD8+ T cells is crucial for activating anti-tumor T cells, and neutralizing IFN-γ in mice impairs control over melanoma progression (48). The gene discussed is CD8A; the disease is neoplasm.